Cerilliant Snap-N-Spike stable-labelled internal standards of antifungal agents

Wednesday, 10 June, 2015 | Supplied by: Merck


Cerilliant has introduced five stable-labelled internal standards of the antifungal agents fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole at 1 mg/mL concentrations. The certified reference materials offer clinical and diagnostic testing labs, hospitals and bioanalytical/PKDM labs a full selection of internal standards for quantitation of the most common antifungal drugs in serum or plasma by mass spectrometry-based analytical methods.

The certified reference solutions are manufactured and certified to industry standards, including ISO Guide 34, ISO/IEC 17025 and ISO 13485, and are compliant with ISO 15194. The deuterium or 13C substitutions of each internal standard were carefully chosen to conserve a minimum [M+3] separation from the unlabelled drug in the major ion fragments used in LC-MS/MS antifungal TDM applications and metabolism studies.

The internal standards complement Cerilliant’s catalogue of triazole, imidazole and other azole antifungal certified spiking solutions. The company will also introduce stable-labelled internal standards for the antifungal metronidazole and active metabolite hydroxyitraconazole.

Online: www.sigmaaldrich.com
Phone: 02 9841 0555
Related Products

Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers

The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...

RevMAb Biosciences histone family protein monoclonal antibodies

RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...

Biosensis MAP2 antibodies

Biosensis's validated MAP2 antibodies are designed to help users identify MAP2, whether they...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd